Cargando…

Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer

Breathlessness is among the most common and deteriorating symptoms in patients with advanced cancer, which may worsen towards the end of life. Breathlessness in patients with estimated life expectancy of weeks to days has unique clinical features: it tends to worsen rapidly over days to hours as dea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Masanori, Yamaguchi, Takashi, Matsuda, Yoshinobu, Suzuki, Kozue, Watanabe, Hiroaki, Matsunuma, Ryo, Kako, Jun, Imai, Kengo, Usui, Yuko, Matsumoto, Yoshihisa, Hui, David, Currow, David, Morita, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046422/
https://www.ncbi.nlm.nih.gov/pubmed/33558034
http://dx.doi.org/10.1136/esmoopen-2019-000603
_version_ 1783501949909336064
author Mori, Masanori
Yamaguchi, Takashi
Matsuda, Yoshinobu
Suzuki, Kozue
Watanabe, Hiroaki
Matsunuma, Ryo
Kako, Jun
Imai, Kengo
Usui, Yuko
Matsumoto, Yoshihisa
Hui, David
Currow, David
Morita, Tatsuya
author_facet Mori, Masanori
Yamaguchi, Takashi
Matsuda, Yoshinobu
Suzuki, Kozue
Watanabe, Hiroaki
Matsunuma, Ryo
Kako, Jun
Imai, Kengo
Usui, Yuko
Matsumoto, Yoshihisa
Hui, David
Currow, David
Morita, Tatsuya
author_sort Mori, Masanori
collection PubMed
description Breathlessness is among the most common and deteriorating symptoms in patients with advanced cancer, which may worsen towards the end of life. Breathlessness in patients with estimated life expectancy of weeks to days has unique clinical features: it tends to worsen rapidly over days to hours as death approaches often despite current symptom control measures. Breathlessness in patients during the last weeks to days of life can be called ‘terminal breathlessness’. While evidence has accumulated for the management of breathlessness in patients with cancer who are not dying, such evidence may not be fully applied to terminal breathlessness. Only a few studies have investigated the best practice of terminal breathlessness in patients with cancer. In this paper, we summarise the current evidence for the management of terminal breathlessness, and propose future directions of clinical research.
format Online
Article
Text
id pubmed-7046422
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70464222020-03-09 Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer Mori, Masanori Yamaguchi, Takashi Matsuda, Yoshinobu Suzuki, Kozue Watanabe, Hiroaki Matsunuma, Ryo Kako, Jun Imai, Kengo Usui, Yuko Matsumoto, Yoshihisa Hui, David Currow, David Morita, Tatsuya ESMO Open Review Breathlessness is among the most common and deteriorating symptoms in patients with advanced cancer, which may worsen towards the end of life. Breathlessness in patients with estimated life expectancy of weeks to days has unique clinical features: it tends to worsen rapidly over days to hours as death approaches often despite current symptom control measures. Breathlessness in patients during the last weeks to days of life can be called ‘terminal breathlessness’. While evidence has accumulated for the management of breathlessness in patients with cancer who are not dying, such evidence may not be fully applied to terminal breathlessness. Only a few studies have investigated the best practice of terminal breathlessness in patients with cancer. In this paper, we summarise the current evidence for the management of terminal breathlessness, and propose future directions of clinical research. BMJ Publishing Group 2020-02-04 /pmc/articles/PMC7046422/ /pubmed/33558034 http://dx.doi.org/10.1136/esmoopen-2019-000603 Text en © Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Review
Mori, Masanori
Yamaguchi, Takashi
Matsuda, Yoshinobu
Suzuki, Kozue
Watanabe, Hiroaki
Matsunuma, Ryo
Kako, Jun
Imai, Kengo
Usui, Yuko
Matsumoto, Yoshihisa
Hui, David
Currow, David
Morita, Tatsuya
Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
title Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
title_full Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
title_fullStr Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
title_full_unstemmed Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
title_short Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
title_sort unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046422/
https://www.ncbi.nlm.nih.gov/pubmed/33558034
http://dx.doi.org/10.1136/esmoopen-2019-000603
work_keys_str_mv AT morimasanori unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT yamaguchitakashi unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT matsudayoshinobu unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT suzukikozue unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT watanabehiroaki unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT matsunumaryo unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT kakojun unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT imaikengo unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT usuiyuko unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT matsumotoyoshihisa unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT huidavid unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT currowdavid unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer
AT moritatatsuya unansweredquestionsandfuturedirectioninthemanagementofterminalbreathlessnessinpatientswithcancer